Paper · 5427331
Mortality in acromegaly.
Wright AD and 3 others. Q J Med, 1970. Cited by 494 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Mortality in acromegaly. Papers, record 5427331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5427331
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acromegaly | Major topic |
| Adolescent | |
| Adult | |
| Age Factors | |
| Aged | |
| Analysis of Variance | |
| Blood Pressure | |
| Brain Diseases | |
| Cardiovascular Diseases | |
| Child | |
| Child, Preschool | |
| Diabetes Complications | |
| Female | |
| Humans | |
| Hypophysectomy | |
| Infant | |
| Male | |
| Middle Aged | |
| Optic Chiasm | |
| Respiratory Tract Diseases |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00461149 | Dose Escalation of Octreotide-LAR as First-Line Therapy in Resistant Acromegaly | Results |
Source ClinicalTrials.gov
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by100
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 494 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,029,663 | Acromegaly and cardiovascular disease: mechanisms, clinical impact, and evolving management. | Endocr Rev | 2026 | https://conductscience.org/library/papers/42029663 | PubMed |
| 41,961,594 | Changing understanding of acromegaly epidemiology and early mortality risk. | J Clin Endocrinol Metab | 2026 | https://conductscience.org/library/papers/41961594 | PubMed |
| 38,337,125 | The changing landscape of acromegaly - an epidemiological perspective. | Rev Endocr Metab Disord | 2024 | https://conductscience.org/library/papers/38337125 | PubMed |
| 38,214,852 | Disease control of acromegaly does not prevent excess mortality in the long term: results of a nationwide survey in Italy. | J Endocrinol Invest | 2024 | https://conductscience.org/library/papers/38214852 | PubMed |
| 36,578,965 | Pituitary adenomas and cerebrovascular disease: A review on pathophysiology, prevalence, and treatment. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/36578965 | PubMed |
| 36,326,330 | Assessment of Tp-e interval, Tp-e/QT, and Tp-e/QTc ratios in patients with acromegaly. | Turk J Med Sci | 2022 | https://conductscience.org/library/papers/36326330 | PubMed |
| 35,975,262 | EMPTY SELLA IN A PATIENT WITH CLINICAL AND BIOCHEMICAL DIAGNOSIS OF ACROMEGALY. | Acta Endocrinol (Buchar) | 2022 | https://conductscience.org/library/papers/35975262 | PubMed |
| 35,596,917 | Association between insulin-like growth factor-1 and cardiovascular events: a systematic review and dose-response meta-analysis of cohort studies. | J Endocrinol Invest | 2022 | https://conductscience.org/library/papers/35596917 | PubMed |
| 34,245,408 | A comparative study on cephalometric differences in maxillofacial morphology between skeletal Class III cases with and without acromegaly: a pilot study. | Oral Radiol | 2022 | https://conductscience.org/library/papers/34245408 | PubMed |
| 33,959,447 | Mortality in Acromegalic Patients: Etiology, Trends, and Risk Factors. | Cureus | 2021 | https://conductscience.org/library/papers/33959447 | PubMed |
1 to 10 of 100
See all 100 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| OCTREOTIDE | CHEMBL1680 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL1680 |
Source ChEMBL
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/5427331
GET https://conductscience.org/api/papers/v1/5427331/cited_by?page=2